1,009
Views
3
CrossRef citations to date
0
Altmetric
Original Articles

Patterns and predictors of outpatient opioid use after cytoreductive surgery with hyperthermic intraperitoneal chemotherapy

, , , ORCID Icon, , & show all
Pages 1057-1063 | Received 10 May 2019, Accepted 19 Sep 2019, Published online: 24 Oct 2019

References

  • Brummett CM, Waljee JF, Goesling J, et al. New persistent opioid use after minor and major surgical procedures in US adults. JAMA Surg. 2017;152(6):e170504.
  • Clarke H, Soneji N, Ko DT, et al. Rates and risk factors for prolonged opioid use after major surgery: population based cohort study. BMJ. 2014;348:g1251.
  • Lee JS, Hu HM, Edelman AL, et al. New persistent opioid use among patients with cancer after curative-intent surgery. J Clin Oncol. 2017;35(36):4042–4049.
  • Caraceni A, Hanks G, Kaasa S, et al. Use of opioid analgesics in the treatment of cancer pain: evidence-based recommendations from the EAPC. Lancet Oncol. 2012;13(2):e58–e68.
  • Sugarbaker PH. Management of peritoneal metastases - basic concepts. J Buon. 2015;20(Suppl 1):S2–S11.
  • Owusu-Agyemang P, Cata JP, Fournier KF, et al. Evaluating the impact of total intravenous anesthesia on the clinical outcomes and perioperative NLR and PLR profiles of patients undergoing cytoreductive surgery with hyperthermic intraperitoneal chemotherapy. Ann Surg Oncol. 2016;23(8):2419–2429.
  • Morris RS, Gani F, Hammad AY, et al. Factors associated with palliative care use in patients undergoing cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. J Surg Res. 2017;211:79–86.
  • Said ET, Sztain JF, Abramson WB, et al. A dedicated acute pain service is associated with reduced postoperative opioid requirements in patients undergoing cytoreductive surgery with hyperthermic intraperitoneal chemotherapy. Anesth Anal. 2018;127(4):1044–1050.
  • Tsilimparis N, Bockelmann C, Raue W, et al. Quality of life in patients after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: is it worth the risk? Ann Surg Oncol. 2013;20(1):226–232.
  • Seretis C, Youssef H. Quality of life after cytoreductive surgery and intraoperative hyperthermic intraperitoneal chemotherapy for peritoneal surface malignancies: a systematic review. Eur J Surg Oncol. 2014;40(12):1605–1613.
  • Clavien PA, Barkun J, de Oliveira ML, et al. The Clavien-Dindo classification of surgical complications: five-year experience. Ann Surg. 2009;250(2):187–196.
  • Bicket MC, Murimi IB, Mansour O, et al. Association of new opioid continuation with surgical specialty and type in the United States. Am J Surg. 2019. DOI:10.1016/j.amjsurg.2019.04.010
  • Ladha KS, Patorno E, Liu J, et al. Impact of perioperative epidural placement on postdischarge opioid use in patients undergoing abdominal surgery. Anesthesiology. 2016;24(2):396–403.
  • Sugarbaker P. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in the management of gastrointestinal cancers with peritoneal metastases: progress toward a new standard of care. Cancer Treat Rev. 2016;48:42–49.
  • Owusu-Agyemang P, Cata JP, Meter AV, et al. Perioperative factors associated with persistent opioid use after extensive abdominal surgery in children and adolescents: a retrospective cohort study. Pediatr Anaesth. 2018;28(7):625–631.
  • Chia YY, Liu K, Wang JJ, et al. Intraoperative high dose fentanyl induces postoperative fentanyl tolerance. Can J Anesth. 1999;46(9):872–877.
  • Chu LF, Angst MS, Clark D. Opioid-induced hyperalgesia in humans: molecular mechanisms and clinical considerations. Clin J Pain. 2008;24(6):479–496.
  • Joseph EK, Reichling DB, Levine JD. Shared mechanisms for opioid tolerance and a transition to chronic pain. J Neurosci. 2010;30(13):4660–4666.
  • Lyons PJ, Rivosecchi RM, Nery JP, et al. Fentanyl-induced hyperalgesia in acute pain management. J Pain Palliat Care Pharmacother. 2015;29(2):153–160.
  • Chu LF, Clark DJ, Angst MS. Opioid tolerance and hyperalgesia in chronic pain patients after one month of oral morphine therapy: a preliminary prospective study. J Pain. 2006;7(1):43–48.
  • Mauermann E, Filitz J, Dolder P, et al. Does fentanyl lead to opioid-induced hyperalgesia in healthy volunteers?: A double-blind, randomized, crossover trial. Anesthesiology. 2016;124(2):453–463.
  • McNicol ED, Tzortzopoulou A, Cepeda MS, et al. Single-dose intravenous paracetamol or propacetamol for prevention or treatment of postoperative pain: a systematic review and meta-analysis. Br J Anaesth. 2011;106(6):764–775.
  • Kurd MF, Kreitz T, Schroeder G, et al. The role of multimodal analgesia in spine surgery. J Am Acad Orthop Surg. 2017;25(4):260–268.
  • Bredlau A, Thakur R, Korones D, et al. Ketamine for pain in adults and children with cancer: a systematic review and synthesis of the literature. Pain Med. 2013;14(10):1505–1517.
  • Gilron I. Gabapentin and pregabalin for chronic neuropathic and early postsurgical pain: current evidence and future directions. Curr Opin Anaesthesiol. 2007;20(5):456–472.
  • Elia N, Lysakowski C, Tramer MR. Does multimodal analgesia with acetaminophen, nonsteroidal antiinflammatory drugs, or selective cyclooxygenase-2 inhibitors and patient-controlled analgesia morphine offer advantages over morphine alone? Meta-analyses of randomized trials. Anesthesiology. 2005;103(6):1296–1304.
  • Hah JM, Bateman BT, Ratliff J, et al. Chronic opioid use after surgery: implications for perioperative management in the face of the opioid epidemic. Anesth Analg. 2017;125(5):1733–1740.
  • Shinde S, Gordon P, Sharma P, et al. Use of non-opioid analgesics as adjuvants to opioid analgesia for cancer pain management in an inpatient palliative unit: does this improve pain control and reduce opioid requirements? Support Care Cancer. 2015;23(3):695–703.
  • Perez J, Olivier S, Rampakakis E, et al. The McGill University Health Centre Cancer Pain Clinic: a retrospective analysis of an interdisciplinary approach to cancer pain management. Pain Res Manag. 2016;2016:1.
  • Lillemoe HA, Newhook TE, Vreeland TJ, et al. Educating surgical oncology providers on perioperative opioid use: results of a departmental survey on perceptions of opioid needs and prescribing habits. Ann Surg Oncol. 2019;26(7):2011.
  • Wyse JJ, Ganzini L, Dobscha SK, et al. Setting expectations, following orders, safety, and standardization: clinicians' strategies to guide difficult conversations about opioid prescribing. J Gen Intern Med. 2019;34(7):1200.
  • Mark J, Argentieri DM, Gutierrez CA, et al. Ultrarestrictive opioid prescription protocol for pain management after gynecologic and abdominal surgery. JAMA Netw Open. 2018;71(8):e185452.
  • Alam A, Gomes T, Zheng H, et al. Long-term analgesic use after low-risk surgery: a retrospective cohort study. Arch Intern Med. 2012;172(5):425–430.
  • Arthur J, Reddy A. Opioid prescribing in an opioid crisis: what basic skills should an oncologist have regarding opioid therapy? Curr Treat Options Oncol. 2019;20(5):39.
  • Yennurajalingam S, Edwards T, Arthur JA, et al. Predicting the risk for aberrant opioid use behavior in patients receiving outpatient supportive care consultation at a comprehensive cancer center. Cancer. 2018;124(19):3942–3949.
  • Bakhshaie J, Rogers AH, Kauffman BY, et al. Emotion dysregulation as an explanatory factor in the relation between negative affectivity and non-medical use of opioid in a diverse young adult sample. Addict Behav. 2019;95:103–109.
  • Rogers AH, Shepherd JM, Orr MF, et al. Exploring anxiety sensitivity in the relationship between pain intensity and opioid misuse among opioid-using adults with chronic pain. J Psychiatr Res. 2019;111:154–159.